Bepreve (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the Bepreve drug offered from Bausch & Lomb Incorporated. This Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
| NON-PROPRIETARY NAME: | bepotastine besilate |
| SUBSTANCE NAME: | BEPOTASTINE BESILATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histamine-1 Receptor Antagonist [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-09-08 |
| END MARKETING DATE: | 0000-00-00 |
Bepreve HUMAN PRESCRIPTION DRUG Details:
| Item Description | Bepreve from Bausch & Lomb Incorporated |
| LABELER NAME: | Bausch & Lomb Incorporated |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/mL) |
| START MARKETING DATE: | 2009-09-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 24208-629_edb50e66-e407-4d18-874a-4516802a30ed |
| PRODUCT NDC: | 24208-629 |
| APPLICATION NUMBER: | NDA022288 |
Other BEPOTASTINE BESILATE Pharmaceutical Manufacturers / Labelers:
